ReShape Lifesciences Inc.
Thomas Stankovich has held various Chief Financial Officer positions in prestigious life sciences companies such as Reshape Lifesciences Inc, MP Biomedicals, Response Genetics, and Cobalis Corp. With a Bachelor's Degree in Finance & Accounting from California State University, Northridge, Thomas has consistently proven their expertise in financial management and leadership, overseeing multinational operations and raising capital for important projects.
ReShape Lifesciences Inc.
ReShape Lifesciences Inc. is America’s premier weight-loss and metabolic health-solutions company, offering an integrated approach to managing and treating obesity. The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The recently launched 𝗋𝖾𝗌𝗁𝖺𝗉𝖾𝗰𝗮𝗿𝗲™ virtual health coaching program is a reimbursed, virtual tele-health, weight-management program that supports lifestyles changes for al weight-loss patients, to help them keep the weight off over time. Together, we will build a healthy life, one choice at a time.